Squamous cell carcinoma of the oral cavity | Squamous cell carcinoma of oropharynx
Item
untreated squamous cell carcinoma of the oral cavity or oropharynx.
boolean
C0585362 (UMLS CUI [1])
C0280313 (UMLS CUI [2])
Age
Item
older than 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
understand and sign informed consent.
boolean
C0021430 (UMLS CUI [1])
Therapeutic procedure Malignant Neoplasm Affected | Chemotherapy | Immunotherapy | Hormone Therapy | Therapeutic radiology procedure | Therapeutic procedure Similar Malignant Neoplasms
Item
any prior treatment of the index cancer (chemotherapy, immunotherapy, hormonal therapy or radiation therapy) or similar treatment of an unrelated malignancy within 6 weeks of enrollment into this study.
boolean
C0087111 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0392760 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C0279025 (UMLS CUI [4])
C1522449 (UMLS CUI [5])
C0087111 (UMLS CUI [6,1])
C2348205 (UMLS CUI [6,2])
C0006826 (UMLS CUI [6,3])
Breast Feeding | Pregnancy | Postmenopausal state | Childbearing Potential Contraceptive methods Inadequate | Sexual Abstinence | Intrauterine Devices | Contraceptives, Oral | Vaginal Spermicides | Vaginal contraceptive diaphragm | Female Condoms | Menstruation
Item
breast-feeding, pregnancy or of childbearing potential (including at least two years post menopause) and unable to confirm adequate contraception (abstinence, iud, birth control pills, or spermicidal gel with diaphragm or condom) since last menses.
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C3831118 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C0205412 (UMLS CUI [4,3])
C0036899 (UMLS CUI [5])
C0021900 (UMLS CUI [6])
C0009905 (UMLS CUI [7])
C0087145 (UMLS CUI [8])
C0042241 (UMLS CUI [9])
C0221829 (UMLS CUI [10])
C0025344 (UMLS CUI [11])
Ulcer of esophagus | Gastric ulcer | Duodenal Ulcer
Item
history of esophageal, gastric or duodenal ulceration within 6 weeks of enrollment.
boolean
C0151970 (UMLS CUI [1])
C0038358 (UMLS CUI [2])
C0013295 (UMLS CUI [3])
Kidney Diseases | Chronic Kidney Diseases | Creatinine measurement
Item
history of acute or chronic renal disorder (blood creatinine level > 1.5 mg/dl).
boolean
C0022658 (UMLS CUI [1])
C1561643 (UMLS CUI [2])
C0201975 (UMLS CUI [3])
Liver diseases | Chronic liver disease | Blood Coagulation Disorders Significant
Item
history of acute or chronic hepatic disorder or a significant bleeding disorder.
boolean
C0023895 (UMLS CUI [1])
C0341439 (UMLS CUI [2])
C0005779 (UMLS CUI [3,1])
C0750502 (UMLS CUI [3,2])
Chronic inflammatory disorder | Ulcerative Colitis | Crohn Disease | Rheumatoid Arthritis | Pancreatitis
Item
history of chronic inflammatory disease (e.g. ulcerative colitis, crohn's disease,rheumatoid arthritis or pancreatitis).
boolean
C1290886 (UMLS CUI [1])
C0009324 (UMLS CUI [2])
C0010346 (UMLS CUI [3])
C0003873 (UMLS CUI [4])
C0030305 (UMLS CUI [5])
Myocardial Infarction | Angina Pectoris | Coronary Artery Disease | Heart Diseases
Item
history of myocardial infarction, angina, or coronary artery disease within the past 6 months, or active cardiac disease.
boolean
C0027051 (UMLS CUI [1])
C0002962 (UMLS CUI [2])
C1956346 (UMLS CUI [3])
C0018799 (UMLS CUI [4])
Cardiac Status New York Heart Association Classification
Item
the subject is of new york heart association (nyha) class 3 or 4 cardiac status.
boolean
C1999091 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Adrenal Cortex Hormones | Nasal Sprays Topical
Item
corticosteroid use within 6 weeks of enrollment, excluding topical nasal sprays.
boolean
C0001617 (UMLS CUI [1])
C2608293 (UMLS CUI [2,1])
C1522168 (UMLS CUI [2,2])
Anti-Inflammatory Agents, Non-Steroidal | celecoxib | Aspirin U/day
Item
nsaid (including celecoxib) or aspirin (> 81 mg/day) use within 1 week of enrollment.
boolean
C0003211 (UMLS CUI [1])
C0538927 (UMLS CUI [2])
C0004057 (UMLS CUI [3,1])
C0456683 (UMLS CUI [3,2])
allergy to COX-2 inhibitors | allergy to nonsteroidal anti-inflammatory agents | Salicylate allergy | Allergy to sulfonamides
Item
history of hypersensitivity to cox-2 inhibitors, nsaids, salicylates, or sulfonamides.
boolean
C2136452 (UMLS CUI [1])
C0746949 (UMLS CUI [2])
C0570514 (UMLS CUI [3])
C0038757 (UMLS CUI [4])
Fluconazole | Lithium
Item
currently taking fluconazole or lithium.
boolean
C0016277 (UMLS CUI [1])
C0023870 (UMLS CUI [2])
Investigational New Drugs
Item
investigational medication use within 6 weeks of enrollment or is scheduled to receive an investigational drug during the course of the study.
boolean
C0013230 (UMLS CUI [1])
Compliance behavior Lacking High risk
Item
principal investigator deems subject to be at high risk for non-compliance.
boolean
C1321605 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
C0332167 (UMLS CUI [1,3])